Nexus Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$922K Sell
769
-30
-4% -$30.7K 0.12% 31
2026
Q1
$735K Hold
799
0.1% 34
2025
Q4
$859K Hold
799
0.12% 30
2025
Q3
$610K Sell
799
-10
-1% -$7.44K 0.09% 34
2025
Q2
$631K Hold
809
0.09% 33
2025
Q1
$961K Hold
809
0.11% 33
2024
Q4
$625K Hold
809
0.06% 52
2024
Q3
$717K Sell
809
-17
-2% -$15.3K 0.07% 53
2024
Q2
$748K Hold
826
0.08% 52
2024
Q1
$643K Hold
826
0.06% 56
2023
Q4
$481K Hold
826
0.05% 60
2023
Q3
$444K Hold
826
0.05% 60
2023
Q2
$387K Hold
826
0.04% 60
2023
Q1
$284K Hold
826
0.03% 64
2022
Q4
$302K Buy
+826
New +$293K 0.03% 65
2016
Q1
Sell
-4,000
Closed -$337K 71
2015
Q4
$337K Hold
4,000
0.07% 62
2015
Q3
$335K Hold
4,000
0.07% 58
2015
Q2
$334K Hold
4,000
0.06% 57
2015
Q1
$291K Hold
4,000
0.06% 60
2014
Q4
$276K Hold
4,000
0.05% 61
2014
Q3
$259K Hold
4,000
0.05% 60
2014
Q2
$249K Hold
4,000
0.05% 63
2014
Q1
$235K Sell
4,000
-710
-15% -$39.6K 0.05% 62
2013
Q4
$240K Hold
4,710
0.05% 61
2013
Q3
$237K Buy
4,710
+210
+5% +$11K 0.05% 61
2013
Q2
$231K Buy
+4,500
New +$245K 0.05% 61

Other funds holding LLY

Nexus Investment Management's LLY Position: Q2 2026 in Review

Nexus Investment Management reduced its Eli Lilly (LLY) stake by 3.8% in Q2 2026, selling an estimated $30.7K and leaving 769 shares worth $922K. The position accounts for 0.12% of the portfolio, ranked #31.

Nexus Investment Management first reported a position in LLY in Q2 2013 and has held it in 26 quarters since. The position peaked at $961K in Q1 2025. 1,691 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Nexus Investment Management held 769 shares of Eli Lilly worth $922K as of Q2 2026.
  • Nexus Investment Management sold 30 Eli Lilly shares in Q2 2026, an estimated $30.7K.
  • Eli Lilly made up 0.12% of Nexus Investment Management's portfolio in Q2 2026, its #31 holding.
  • Nexus Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 26 quarters since.
  • Nexus Investment Management's Eli Lilly position peaked at $961K in Q1 2025.
  • 1,691 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Nexus Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.